[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ITRM20020370A0 - PEPTIDE-MIMETIC COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRIN INHIBITOR. - Google Patents

PEPTIDE-MIMETIC COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRIN INHIBITOR.

Info

Publication number
ITRM20020370A0
ITRM20020370A0 IT2002RM000370A ITRM20020370A ITRM20020370A0 IT RM20020370 A0 ITRM20020370 A0 IT RM20020370A0 IT 2002RM000370 A IT2002RM000370 A IT 2002RM000370A IT RM20020370 A ITRM20020370 A IT RM20020370A IT RM20020370 A0 ITRM20020370 A0 IT RM20020370A0
Authority
IT
Italy
Prior art keywords
peptide
compound containing
rgd sequence
integrin inhibitor
sequence useful
Prior art date
Application number
IT2002RM000370A
Other languages
Italian (it)
Inventor
Mauro Marzi
Giuseppe Giannini
Domenico Alloatti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT2002RM000370A priority Critical patent/ITRM20020370A1/en
Publication of ITRM20020370A0 publication Critical patent/ITRM20020370A0/en
Priority to PCT/IT2003/000422 priority patent/WO2004005328A2/en
Priority to AU2003281226A priority patent/AU2003281226A1/en
Publication of ITRM20020370A1 publication Critical patent/ITRM20020370A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT2002RM000370A 2002-07-09 2002-07-09 PEPTID-CAMOID COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRINE INHIBITOR. ITRM20020370A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2002RM000370A ITRM20020370A1 (en) 2002-07-09 2002-07-09 PEPTID-CAMOID COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRINE INHIBITOR.
PCT/IT2003/000422 WO2004005328A2 (en) 2002-07-09 2003-07-03 Peptidomimetic compound useful as inhibitor of integrins
AU2003281226A AU2003281226A1 (en) 2002-07-09 2003-07-03 Peptidomimetic compound useful as inhibitor of integrins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002RM000370A ITRM20020370A1 (en) 2002-07-09 2002-07-09 PEPTID-CAMOID COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRINE INHIBITOR.

Publications (2)

Publication Number Publication Date
ITRM20020370A0 true ITRM20020370A0 (en) 2002-07-09
ITRM20020370A1 ITRM20020370A1 (en) 2004-01-09

Family

ID=11456401

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002RM000370A ITRM20020370A1 (en) 2002-07-09 2002-07-09 PEPTID-CAMOID COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRINE INHIBITOR.

Country Status (3)

Country Link
AU (1) AU2003281226A1 (en)
IT (1) ITRM20020370A1 (en)
WO (1) WO2004005328A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006048473A1 (en) * 2004-10-30 2006-05-11 Universidad Del Pais Vasco/Euskal Herriko Unibertsitatea β-LACTAMIC RGD CYCLOPEPTIDES CONTAINING GAMMA (Ϝ) TURNS
CN103374056B (en) * 2012-04-20 2017-02-08 首都医科大学 1-Acetyl-beta-carboline-3-formyl amino-acid benzyl ester, and synthesis and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770565A (en) * 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
US6482821B2 (en) * 1996-12-20 2002-11-19 Hoechst Aktiengellschaft Vitronectin receptor antagonists, their preparation and their use
US6235877B1 (en) * 1999-08-04 2001-05-22 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors

Also Published As

Publication number Publication date
WO2004005328A2 (en) 2004-01-15
AU2003281226A8 (en) 2004-01-23
ITRM20020370A1 (en) 2004-01-09
WO2004005328A3 (en) 2004-02-26
AU2003281226A1 (en) 2004-01-23

Similar Documents

Publication Publication Date Title
ITTO20020167A1 (en) REGRIGERATION CYCLE.
BR0305668B1 (en) compressor.
NO20052149D0 (en) Vaccine.
DE60332985D1 (en) Acoustic-structural low-pressure compressor-flow divider
DK1556377T3 (en) Cyclopropylthienylcarboxamides as fungicides
ITMI20022022A1 (en) ANALOGUES OF NOCICETTINA.
FI20020430A0 (en) shelving system
DE50303886D1 (en) Beam
ITPS20030026A1 (en) STRUCTURE OF OSTEOTOME.
ITRM20020370A0 (en) PEPTIDE-MIMETIC COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRIN INHIBITOR.
ITRM20020470A0 (en) WASHROOM.
ITBO20020759A1 (en) PROCEDURE FOR THE STORAGE OF INFORMATION AD
NO20032952D0 (en) show Packaging
SE0203213L (en) itinerary
FI5810U1 (en) shelf
ITRM20020316A1 (en) FASTENING DOWEL.
ITTO20020322A0 (en) DRAWER STRUCTURE.
ITFO20020004A1 (en) EXCITED WAITER
FI5456U1 (en) wooden beam
ES1053124Y (en) EXHIBITING SHOWCASE.
ITPD20030247A1 (en) PROCEDURE FOR THE REALIZATION OF DISTINCTIVE SIGNS,
ES1053039Y (en) IMPROVED FUELLE STORE.
ITNO20020006A0 (en) SELF-SUPPORTING SHELF
SE0203228D0 (en) Tranemo Beams
ITRM20010403A1 (en) EMISSION FREE GENERATOR.